Mabwell (Shanghai) Bioscience Co (SHSE:688062) Other Operating Expense: ¥298.6 Mil (TTM As of Jun. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Mabwell (Shanghai) Bioscience Co Ltd SHSE:688062

59 GF Score

Price ¥25.51

GF Value ¥133.22

Valuation Possible Value Trap

5 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Mabwell (Shanghai) Bioscience Co Other Operating Expense?

Mabwell (Shanghai) Bioscience Co SHSE:688062 -1.96% 59 Other Operating Expense is ¥298.6 Mil as of Jun. 2026. GuruFocus rates SHSE:688062 with a GF Score™ of 59/100 and a GF Value™ of ¥133.22 (Possible Value Trap). The stock has 5 warning signs investors should review.

Mabwell (Shanghai) Bioscience Co's Other Operating Expense for the three months ended in Jun. 2026 was ¥130.2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ¥298.6 Mil.

Mabwell (Shanghai) Bioscience Co's quarterly Other Operating Expense declined from Dec. 2025 (¥306.1 Mil) to Mar. 2026 (¥0.3 Mil) but then increased from Mar. 2026 (¥0.3 Mil) to Jun. 2026 (¥130.2 Mil).

Mabwell (Shanghai) Bioscience Co's annual Other Operating Expense increased from Dec. 2023 (¥205.3 Mil) to Dec. 2024 (¥233.4 Mil) and increased from Dec. 2024 (¥233.4 Mil) to Dec. 2025 (¥287.8 Mil).

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Mabwell (Shanghai) Bioscience Co Other Operating Expense Related Terms

Mabwell (Shanghai) Bioscience Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Mabwell (Shanghai) Bioscience Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mabwell (Shanghai) Bioscience Co Other Operating Expense Chart

Mabwell (Shanghai) Bioscience Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Other Operating Expense

Get a 7-Day Free Trial

65.83

160.98

205.32

233.40

287.81

Mabwell (Shanghai) Bioscience Co Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Other Operating Expense	Get a 7-Day Free Trial															122.97	-138.00	306.11	0.30	130.24

59GF Score

Mabwell (Shanghai) Bioscience Co Ltd SHSE:688062

Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Mabwell (Shanghai) Bioscience Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥298.6 Mil.

Frequently Asked Questions Learn more about Other Operating Expense →

What does a Other Operating Expense of ¥298.6 Mil mean?

Mabwell (Shanghai) Bioscience Co (SHSE:688062) has a Other Operating Expense of ¥298.6 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Mabwell (Shanghai) Bioscience Co and its competitors.

Is Mabwell (Shanghai) Bioscience Co's Other Operating Expense too high?

Mabwell (Shanghai) Bioscience Co's current Other Operating Expense is ¥298.6 Mil. Overall, Mabwell (Shanghai) Bioscience Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Mabwell (Shanghai) Bioscience Co's Other Operating Expense compare to VRTX and REGN?

Mabwell (Shanghai) Bioscience Co's Other Operating Expense of ¥298.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Other Operating Expense for a Biotechnology company?

A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Other Operating Expense mean?

A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Mabwell (Shanghai) Bioscience Co and its competitors. Mabwell (Shanghai) Bioscience Co's current Other Operating Expense is ¥298.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Mabwell (Shanghai) Bioscience Co stock overvalued right now?

Based on GuruFocus' analysis, Mabwell (Shanghai) Bioscience Co (SHSE:688062) is currently considered Possible Value Trap. The stock's GF Value™ is ¥133.22, compared to a current price of ¥25.51 — trading 80.9% below its estimated fair value. The current Other Operating Expense is ¥298.6 Mil. Mabwell (Shanghai) Bioscience Co's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Other Operating Expense calculated?

Other Operating Expense is calculated from a company's financial statements. For Mabwell (Shanghai) Bioscience Co (SHSE:688062), the current Other Operating Expense is ¥298.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mabwell (Shanghai) Bioscience Co (SHSE:688062) Overvalued in 2026?

Based on GuruFocus' analysis, Mabwell (Shanghai) Bioscience Co stock appears to be undervalued. The current stock price of ¥25.51 is trading 80.9% below its estimated GF Value™ of ¥133.22. GuruFocus considers Mabwell (Shanghai) Bioscience Co to be Possible Value Trap.

Key valuation signals for SHSE:688062:

Other Operating Expense: ¥298.6 Mil
GF Value™: ¥133.22 vs. price of ¥25.51 (80.9% below fair value)
GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688062 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →